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The excited-state kinetics of the fluorescence of tyrosine in a de novo protein fibrillogenesis model 
was investigated as a potential tool for monitoring protein fibre formation and complexation with 
glucose (glycation).  In stark contrast to insulin the time-resolved emission spectra (TRES) recorded 
over the period of 700 hours in buffered solutions of the model with and without glucose revealed no 
apparent changes in Tyr fluorescence responses. This indicates the stability of the model and provides 
a measurement-supported basis for its use as a reference material in fluorescence studies of protein 
aggregation.   
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I. INTRODUCTION  
There is a significant interest in improving the understanding of protein fibrillogenesis. The process is 
fundamentally important for normal and pathological phenomena including those that underpin the 
onset of neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and 
diabetes mellitus type II.
1,2
 These are proteopathic disorders, in which precursor protein undergoes 
abnormal development via a chain of conformational changes resulting in the formation of amyloid 
fibrils. Amyloid aggregation is structurally polymorphic due to the different assembly pathways 
monomeric units are involved in.
3
 As a result, the units can assemble into different populations of 
oligomeric forms characterised by varied growth kinetics. In contrast, normal fibrillogenesis 
processes, such as those supporting the assembly of actin filaments or collagen and fibrin fibrils, 
exhibit more homogenous growth rates. To better understand the rate of fibrillogenesis, it is 
advantageous if the complexity of natural proteins is reduced and fibrillogenesis studies performed 
using simplistic and reproducible models first. Such models can be based on well-established rules of 
sequence-to-structure relationships and offer necessary predictability in control over fibrillogenesis at 
the molecular level. To achieve this, the approach requires a well-characterised protein folding 
element.  
One of such elements is an α-helical coiled coil, which is characteristic of about 5-10% of all amino 
acids in proteins. The sequence-to-structure relationships for this motif are reasonably well 
understood and have been validated in many designs.
4
 The hallmark of canonical alpha-helical coiled 
coils is a heptad repeat of hydrophobic (H) and polar (P) residues, HPPHPPP, which is usually 
designated as abcdefg. This arrangement gives rise to a rope-like bundle of two or more helices 
interdigitated with the formation of a contiguous hydrophobic interface, with each helix having 3.5 
amino-acid residues per turn. Charged residues in g and e sites stabilise the bundle further via 
bridging electrostatic interactions.
5
 
Using these principles a coiled-coil sequence was designed to assemble into filamentous structures 
from the monomer up.
6
 The sequence – KLAALKQKLAALKKELAALEQELAALEQ – was shown 
to adopt a sticky-ended coiled coil oligomer that propagates longitudinally into relatively uniform 
filaments of 2.7 ± 0.3 µm in length. In contrast to amyloid-like fibrils, this assembly is characterised 
by homogenous growth kinetics, with individual fibres exhibiting the same growth rates at both 
growing ends, i.e. N and C-termini. By labelling the peptide with an Alexa Fluor 488 dye it was 
possible to monitor the process of fibrillogenesis in real time by structured illumination microscopy 
(SIM) in solution under static, equilibrium conditions,
6
 and under non-equilibrium conditions by 
applying the coffee ring effect
7
. Under both conditions, the assembly starts with a seeding or initiation 
phase of folded monomeric units, followed by a stabilization phase of laterally equilibrated 
assemblies, and a maturation phase of longitudinally equilibrated assemblies at which fibre formation 
is essentially complete.  
However, extrinsic fluorophores such as Alexa Fluor 488 require covalent conjugation with the 
peptide sequence and once incorporated could in principle interfere with fibrillogenesis
8
. Here we 
probed the feasibility of using an intrinsic fluorophore and replace the lysyl residue in position 14, 
which was used as a fluorophore labelling site, with a tyrosyl residue (see Fig. 1). A single tyrosine 
(Tyr) in each monomer and the lack of tryptophan allows for selective excitation without the 
complication of energy transfer. Tyr is known to be sensitive to local microenvironments e.g. in 
evolving insulin,
9
 during the process of glycation as shown in this paper and in the aggregation of 
beta-amyloid
10
. Therefore, we reason that the fluorescence response of the residue, both steady-state 
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and time-resolved, can be used to monitor fibrillogenesis. In addition, complementary information can 
be obtained using the same approach with regards to complexation with sugar molecules (glycation).  
Protein glycation is a non-enzymatic process, which occurs as a post-folding modification affecting 
protein stability, structure and function. In amyloid deposits, protein is often glycated which suggests 
a correlation between fibrillogenesis and glycation
11
.  
Both the self-assembly of the peptide into fibres and their potential complexation with glucose were 
studied using time-resolved emission spectra (TRES). TRES is a series of the fluorescence emission 
spectra emitted at discrete times after pulse excitation on the nanosecond time scale. Changes in 
TRES of the sample determined and measured over several days were used to correlate with the 
processes of fibrillogenesis and glycation.  
 
II. EXPERIMENTAL 
The peptide was assembled on a Fmoc-Gln(Trt)-Wang resin using a PTI Tribute peptide synthesizer. 
HBTU/DIPEA and piperidine were used as coupling and deprotection reagents, respectively. After the 
synthesis, the peptide was cleaved from the resin following a 2-hour treatment with the cleavage 
cocktail of 95% TFA, 2.5% TIS, 2.5%. Diethyl ether was added to the mixture to precipitate and wash 
the peptide, which was followed by centrifugation at 6,500 rpm (20 min, 3 times). The pellet was then 
purified by a Dionex UltiMate 3000 HPLC system using a semi-preparative column (ACE 5C18-300 
250x10 mm) at a flow rate of 3.5 mL/min. The purity of the peptide was confirmed by analytical 
HPLC (ACE 5C18-300 250x4.6 mm column; at a flow rate of 1 mL/min) and the identity was 
confirmed by MALDI-ToF mass spectrometry: MS [M + H]
+
: m/z 3068.6 (calculated), 3068.6 
(observed). 
Aqueous peptide solutions (300 µL, 50 µM) were prepared in filtered (0.22 µm) 10 mM MOPS, pH 
7.4, and incubated overnight at room temperature for fibrillogenesis. The fluorescence of the peptide 
was measured at 37.5⁰C, pH 7.4 to mimic physiological conditions. For comparative measurements 
bovine insulin (Sigma-Aldrich) was used without further purification. 50 uM solution of bovine 
insulin in PBS (0.01 M). A stock solution of D-(+)-Glucose (Sigma-Aldrich) in distilled water was 
added to the peptide and insulin where the final concentration of glucose was 50 mM. 
Absorption and fluorescence intensity measurements were performed using Lambda 25 (Perkin 
Elmer) and Fluorolog (Horiba Scientific), respectively. Time-resolved fluorescence decays were taken 
on the DeltaFlex fluorescence lifetime system (Horiba Jobin Yvon IBH Ltd, Glasgow) using time 
correlated single photon counting. A NanoLED with a wavelength of 279 nm and producing pulses of 
~600 ps was used for excitation
12
. Fluorescence decays were measured with varying detection 
wavelengths from 290 to 340 nm in 5 nm increments. The decays were fitted to a three-exponential 
model function for each detection wavelength: 
 
 
𝐼𝜆(𝑡) =  ∑ 𝛼𝑖(𝜆) exp (
−𝑡
𝜏𝑖(𝜆)
) 
3
𝑖=1
 (1) 
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The parameters 𝜏𝑖(𝜆) is the fluorescence lifetime and 𝛼𝑖(𝜆) is the i
th
 pre-exponential component. The 
parameters were recovered to generate TRES according to
9
:  
 
𝐼𝑡(𝜆) =  
𝐼𝜆(𝑡) 𝑆(𝜆) 
∑ 𝛼𝑖(𝜆)𝜏𝑖()𝑖
 (2) 
 
𝑆(𝜆) is the emission intensity from the sample and the denominator represents the total emitted 
photons from the fluorescence sample. TRES were then converted to functions of the wavenumbers 
𝐼𝑡(𝑣) according to: 
 𝐼𝑡(𝑣) = 𝜆
2𝐼𝑡(𝜆) (3) 
 
Using the Toptygin-type representation of the TRES
13
 we model 𝐼𝑡(𝑣) by the function: 
𝐹(𝑣) = ∑
𝐶𝑖 
√2𝜋 𝑣𝑖𝜎𝑖(𝑣𝑖
2 + 3𝜎𝑖
2)
𝑣3 𝑒𝑥𝑝 (
−(𝑣 − 𝑣𝑖)
2
2𝜎𝑖
2 )
𝑁
𝑖=1
                    (4) 
where the expression (√2𝜋 𝑣𝑖𝜎𝑖(𝑣𝑖
2 + 3𝜎𝑖
2))
−1
 for each component i is the normalisation factor of 
the 𝑣3 exp [
−(𝑣−𝑣𝑖)
2
2𝜎𝑖
2 ] function. Thus, 𝐶𝑖 coefficient represents fluorescence contribution of the i
th
 
component.  
 
III. RESULTS AND DISCUSSION 
Steady state absorption spectra measured for peptide samples at different times after preparation over 
nearly 700 hours are shown in Fig. 2A. The spectra are dominated by the tyrosine peak absorbance 
around 279 nm and show increasing effect of Rayleigh scattering with sample ageing up to about 450 
hours and then gradual drop in absorbance. At the same period of time, the intensities of fluorescence 
spectra (Fig. 2B) have increased (integrated intensities shown in Fig. 2C) again up to 450 hours, with 
the shape of the spectra changing insignificantly (Fig. 2D), and then started to decrease. The growing 
contributions of the scattered light in the absorption spectra are indicative of oligomeric forms 
increasing in size,
14
 while increases in fluorescence intensity may be attributed to a higher quantum 
yield of tyrosine caused by its gradually decreasing quenching by water.
15
 Both observations are 
consistent with the fibrillogenesis process over the studied period. The potential cause of the 
decreased intensities observed in both spectra is likely to be caused by precipitation of the larger 
fibrils and, consequently, decreasing concentration of the fluorescent material in the solution. 
In the next stage fibrillogenesis was monitored by means of the potential changes in the fluorescence 
intensity decay of Tyr residues. The full set of fluorescence intensity decays for the fibrillating sample 
was measured at wavelengths from 290 nm to 340 nm with 5 nm increments. The series of 
measurements started at a seeding phase in the first 20 min (0.33 h) of sample preparation, with 
subsequent measurements recorded at 22, 43, 68, 95, 201, 312, 381, 454, 527, 600 and 693 hours.  
Fig. 3 presents fluorescence intensity decays recorded at different time points and wavelengths. 
Fluorescence intensity decays recorded at the longer wavelengths show the progressive emergence of 
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a longer decay component, as illustrated in Fig. 3A and B for the earliest (0.33 h) and latest (693 h) 
samples, respectively. This observation is consistent with protein wavelength-lifetime dependence
9,16 
which may be explained by the dielectric relaxation of the fluorophores or by the presence of multiple 
components of different emission spectra and fluorescence lifetimes increasing with emission 
wavelengths. However a substantial contribution of the scattered excitation light in the decay signal 
can also preferentially distort the decay at shorter wavelengths. In order to separate the scattered light 
from the actual fluorescence decays, we used for the data fitting the model decays consisting of the 
both multi-exponential part and the scattered light component.
17
 Tables 1-5 in Supplementary 
Material (SM) show parameters recovered from fitting the 3-exponential model to the data measured 
for the 0.33, 43, 312, 454 and 693 hours old samples respectively, together with the percentage 
contributions of the scattered light Sc() at each detection wavelength . Increased contributions of 
the scattered light were detected in the decays measured at 290 nm due to close distance between the 
excitation and detection wavelength and picking up the excitation light by the detector even at low 
scatter from the sample. We note that due to structural complexity of the sample during fibrillogenesis 
(distribution in fibril’s sizes and structure) and potential effects of dielectric relaxation, the individual 
fluorescence decays cannot be resolved by means of any specific model of kinetics. Instead, the 3-
exponential representations of these decays were used to produce TRES. 
For the protein model, the TRES representation 𝑣−3𝐼𝑡(𝑣) and normalised 𝑣
−3𝐼𝑡(𝑣) were plotted for 
different times after preparation. A few samples of age 0.33, 43 and 693 hours are shown in Fig. 4A, 
C, and E. The fluorescence spectra measured at all stages of fibrillization decay gradually and, at the 
same time, shifts towards smaller wavenumbers (which is better seen in the normalised spectra, Fig. 
4B, D and F). The detailed analysis of the spectra indicates presence of two fluorescent forms with 
emission peaks at ~33,000 and ~31,500 cm
-1
 and the effects of dielectric relaxation in both forms. 
However, the effect of dielectric relaxation is relatively small (~500 cm
-1
). Indeed, the comparison of 
the observed TRES response of Tyr in the protein model with the significant Tyr TRES changes 
observed in insulin (Fig. 4G, H) indicate high stability of the Tyr surroundings in the model peptide. 
To further examine the stability features of the fibrillogenesis model, glucose was added to the sample 
to investigate potential glycation effects. The peptide model was also incubated with glucose for 
nearly 700 hours and the examples of TRES for 0.58, 48, and 693 hours are shown in 5A, C and E, 
respectively. For the sample 0.58 hours old, at 34,500 cm
-1 
the points are outliers after each moment 
of excitation which may be heavily influenced from light scattering as it is close to the excitation 
wavelength (279 nm). The normalised TRES (Fig 5B, D and F) show again small changes within the 
TRES when glucose is present at 48 hours and 693 hours of incubation. As expected (the peptide has 
no binding sites for glucose) no evidence of TRES changes was observed over time, demonstrating 
that the protein model is not prone to glycation.  
For comparison, Fig. 4G, H and 5G, H show the effect glucose has on insulin after 693 hours. In fact, 
insulin’s TRES evolves over time due to insulin aggregation (data not shown), but glycation 
substantially modifies this evolution. Free insulin undergoes drastic spectral changes due to excitation 
triggered conformational changes of insulin. When insulin has been incubated with glucose for 693 
hours, there is a no spectral change after excitation which indicates that there is no conformational 
change and that the structure is rigid. The main targets of glycation are arginine, lysine, cysteine 
residues, and N-terminus of amino groups. For bovine insulin, glycation occurs on Lys (B29) and on 
N-terminus of chains A and B
18
. 
To gather more information on the spectral changes for the peptide, all TRES were fitted by the 
distribution function (eqtn 4). It was necessary to assume N=2 to obtain a good fit, which implies the 
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existence of two fluorescent forms with emission maxima at ~33,000 and ~31,500 cm
-1
 (for the 
freshly prepared sample) evolving differently over the studied period. Fig 6A shows the shifts of 
spectral peak positions following the moment of excitation for the samples measured at different 
times after preparation, while the fluorescence contributions 𝐶𝑖(𝑡) of each component are shown on 
Fig. 6B. The curved shapes of all plots LogI(t) vs. time shows that the kinetics is more complex than 
exponential and both forms decay at similar rates. 
Combined analysis of the TRES and the steady-state data seem to suggest three stages of the model 
fibrillogenesis: During the first 22 hours the 33,000 cm
-1
 form shifts towards shorter wavenumbers by 
~500 cm
-1
 (Fig.6A) while the 31,500 cm
-1
 form shows much larger shift by ~1,500 cm
-1
. Both shifts 
may be related to dielectric relaxation. Moreover, the percentage fluorescence contribution of the 
33,000 cm
-1 
form increases from 63 to 90% (estimated from the initial values of Ci(t) - Fig.6B), while 
the over decreases from 37 to 10%. During this time the initial oligomers are formed and Tyr residues 
experience significant changes in their local environments. 
The second stage covers the period from about 24 hours to ~450 hours. At this time the positions of 
the spectral peaks i(t)and the fluorescence intensity decays Ci(t) do not change significantly. The 
increasing intensity of the steady-state fluorescence observed during this period (Fig.2B) and no 
changes recorded in lifetimes can be explained by initial oligomers showing low quantum yield of 
fluorescence (due to static quenching by water), but become more fluorescent once incorporated into 
fibres.  
The third stage begins after ~450 hours, when the TRES parameters remain stable and the rates of the 
decays Ci(t) do not change substantially, but the peak intensities of the absorption and fluorescence 
spectra start to drop (Fig.2A nd 2B). This effect is consistent with the formation of larger forms that 
precipitate, which effectively reduces the concentration of fluorescent material in the sample. The 
process does not affect the detected fluorescence decays, which are independent of fluorophore 
concentration and because precipitation applies to the larger fibrils the local environments of tyrosines 
under measurement are unaffected. This suggestion is consistent with the increasing number of 
monomers in the growing fibrils. In the previous studies of the model prepared under similar 
conditions
6
, the calculated number of monomers in a fibril was 225x10
3
. Clearly the fibrillogenesis of 
the structures of this size is not reflected in changes of intrinsic fluorescence.  
IV. CONCLUSION 
In conclusion, the increased scatter and changes in fluorescence intensity observed during the whole 
monitored period of ~700 hours suggest an equilibrated fibrillogenesis of the model peptide, while the 
photophysics of the Tyr residue is not affected directly during the most of the process except for the 
initial stage, i.e. formation of initial oligomers during about 24 hours. Tyrosines in other peptides and 
proteins (e.g. insulin) report their structural changes over much longer time, which allows using the 
model peptide we studied as a useful reference in similar TRES experiments. Simultaneously, the 
fibrillogenesis model can also be probed by means of the time-resolved anisotropy of tyrosine, 
𝑟(𝑡) = (𝑟0 − 𝑟∞) exp (−
𝑡
𝜏𝑟
) + 𝑟∞, where the rotational time 𝜏𝑟 and the final anisotropy 𝑟∞ are likely 
to increase due to increasing size of the fibrils.  
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Figures captions: 
 
Figure 1: Fibrillogenesis model design. (A) The linear amino-acid sequence of the protein model, 
three copies of which form a staggered coiled-coil unit with cationic and anionic overhangs, each 
having two heptads. (B) The unit configured into coiled-coil helical wheels with 3.5 residues per turn. 
(C) A ribbon diagram of the staggered unit (PDB 3L4F entry rendered with PyMol). (D) A schematic 
representation of the longitudinal propagation of the unit into a contiguous coiled coil. For clarity only 
one coiled coil is shown: resulting fibrils are bundles of individual coiled coils. Key: cationic and 
anionic heptads and residues are shown in blue and red, respectively. Double-headed arrows indicate 
electrostatic interactions between lysines and glutamates. One of the two combinations of interactions, 
highlighted by bold and dashed arrows, can be formed within one coiled coil unit. Asterisks indicate 
the Tyr residue. 
 
Figure 2: Steady state measurements A) absorbance and B) emission of the protein fibrillogenesis 
model for 0, 22, 43, 68, 95, 201, 312, 381, 454, 527, 600 and 693 hours after sample preparation. The 
integrated fluorescence intensity C) and normalised emission spectra D) were also plotted. 
 
Figure 3: The instrumental pulse profile (black) and fluorescence intensity decays for detection 
wavelengths of 290, 295, 300, 305, 310, 315, 320, 325, 330, 335 and 340 nm for A) 0.33 and B) 693 
hours after sample preparation of fibrillogenesis model. 
 
Figure 4: The left hand panel show the TRES spectra of the peptide model (A, C, E) and insulin (G) 
for 0.33, 43, and 693 hours respectively. The right hand panel shows the normalised TRES plots for 
the free peptide model (B, D, F) and insulin (H). The plots were determined at 0, 0.25, 0.5, 0.75, 1, 
1.5, 2, 3, 4, 5, 6, 7, 8, 9, and 10 ns after excitation. 0 ns is taken out of 0.33 hours of the peptide model 
and 693 hours of insulin due to high scatter. 
 
Figure 5: The left hand panel show the TRES spectra of the peptide model (A, C, E) and insulin (G) in 
the presence of glucose at times 0.58, 48, and 693 hours respectively. The right hand panel shows the 
normalised TRES plots for the free peptide model (B, D, F) and insulin (H). The plots were 
determined at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, and 10 ns after excitation. 0 ns is taken out 
of 0.58 hours data due to high scatter. 
 
Figure 6: TRES parameters taken from the 2 Gaussian models of peak positions vi and the corrected 
fluorescence contributions Ci fitted to two exponential models. Fluorescent species 1 () and 2 (●) 
where measured at 0.33, 22, 43, 68, 95, 201, 312, 381, 454, 527, 600, 693 hours after sample 
preparation. 
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Figure 1: Fibrillogenesis model design. (A) The linear amino-acid sequence of the protein model, three copies of 
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Figure 2: Steady state measurements A) absorbance and B) emission of the protein fibrillogenesis model for 0, 22, 43, 
68, 95, 201, 312, 381, 454, 527, 600 and 693 hours after sample preparation. The integrated fluorescence intensity C) 
and normalised emission spectra D) were also plotted.  
 
 
11 
 
20 40 60
1
10
100
1000
10000
20 40 60
1
10
100
1000
10000
T = 693 h
T = 0.33 h
B)
 
 
ln
 I
(t
)
t / ns
340 nm
290 nm
det =
A)
det =
 
 
ln
 I
(t
)
t / ns
340 nm
290 nm
 
 
Figure 3: The instrumental pulse profile (black) and fluorescence intensity decays for detection wavelengths of 290, 
295, 300, 305, 310, 315, 320, 325, 330, 335 and 340 nm for A) 0.33 and B) 693 hours after sample preparation of 
fibrillogenesis model.  
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Figure 4: The left hand panel show the TRES spectra of the peptide model (A, C, E) and insulin (G) for 0.33, 43, and 
693 hours respectively. The right hand panel shows the normalised TRES plots for the free peptide model (B, D, F) 
and insulin (H). The plots were determined at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, and 10 ns after excitation. 0 
ns is taken out of 0.33 hours of the peptide model and 693 hours of insulin due to high scatter. 
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Figure 5: The left hand panel show the TRES spectra of the peptide model (A, C, E) and insulin (G) in the presence of 
glucose at times 0.58, 48, and 693 hours respectively. The right hand panel shows the normalised TRES plots for the 
free peptide model (B, D, F) and insulin (H). The plots were determined at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 
and 10 ns after excitation. 0 ns is taken out of 0.58 hours data due to high scatter.  
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Figure 6: TRES parameters taken from the 2 Gaussian models of peak positions 𝒗𝒊 and the corrected fluorescence 
contributions 𝑪𝒊 fitted to two exponential models. Fluorescent species 1 () and 2 (●) where measured at 0.33, 22, 43, 
68, 95, 201, 312, 381, 454, 527, 600, 693 hours after sample preparation. 
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SUPPLEMENTARY MATERIAL 
 
 
 
 
 
Table 1: Lifetime data extracted from 0.33 hours of ageing fibrillogenesis model including lifetime values (T1, T2, 
T3), pre-exponential values (A1, A2, A3), scatter component (Sc), χ
2
, and absorbance values for each corresponding 
wavelength.  
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Wavelength 
/ nm 
T1 / ns A1 / % T2 / ns A2 / % T3 / ns A3 / % Sc / % χ2 
290 0.02 95.68 1.04 2.78 2.11 1.54 36.82 1.29 
295 0.49 39.29 1.51 53.94 2.84 6.77 0.00 1.3 
300 0.81 49.78 1.84 49.74 6.68 0.48 4.58 1.14 
305 0.39 39.77 1.54 56.74 3.59 3.49 13.39 1.07 
310 0.43 40.11 1.57 57.01 3.85 2.88 2.77 1.05 
315 0.50 39.43 1.62 58.25 4.20 2.32 4.73 1.19 
320 0.45 43.52 1.63 54.77 4.58 1.71 1.15 1.17 
325 0.50 40.44 1.64 57.61 4.63 1.95 5.04 1.11 
330 0.44 40.98 1.58 56.44 4.24 2.58 6.37 1.39 
335 0.56 40.40 1.69 58.06 5.43 1.54 7.00 1.42 
340 0.55 43.62 1.70 54.97 5.88 1.40 4.84 1.16 
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Table 2: Lifetime data extracted from 43 hours of ageing fibrillogenesis model including lifetime values (T1, T2, T3), 
pre-exponential values (A1, A2, A3), scatter component (Sc), χ
2
, and absorbance values for each corresponding 
wavelength.  
 
 
 
 
Table 3: Lifetime data extracted from 312 hours of ageing fibrillogenesis model including lifetime values (T1, T2, T3), 
pre-exponential values (A1, A2, A3), scatter component (Sc), χ
2
, and absorbance values for each corresponding 
wavelength.  
 
 
 
Wavelength 
/ nm 
T1 / ns A1 / % T2 / ns A2 / % T3 / ns A3 / % Sc / % χ2 
290 0.45 43.64 1.57 52.62 3.17 3.74 0.00 1.22 
295 0.42 39.16 1.48 54.25 2.90 6.59 0.00 1.24 
300 0.53 37.83 1.60 58.34 3.44 3.83 5.93 1.16 
305 0.49 38.28 1.60 58.93 3.90 2.79 5.17 1.08 
310 0.54 37.84 1.61 59.21 3.91 2.95 5.34 1.18 
315 0.54 36.89 1.63 60.59 4.16 2.52 5.48 1.08 
320 0.44 43.54 1.64 54.83 4.71 1.63 0.00 1.10 
325 0.65 41.89 1.74 56.69 5.23 1.42 6.28 1.09 
330 0.55 41.67 1.72 56.81 5.24 1.53 3.49 1.16 
335 0.59 42.23 1.72 56.35 5.62 1.42 4.79 1.16 
340 0.59 42.14 1.73 56.58 6.32 1.28 5.61 1.19 
Wavelength 
/ nm 
T1 / ns A1 / % T2 / ns A2 / % T3 / ns A3 / % Sc / % χ2 
290 0.44 37.59 1.48 55.24 2.82 7.17 5.90 1.22 
295 0.55 38.96 1.62 58.05 3.52 3.00 6.73 1.19 
300 0.46 41.88 1.58 54.94 3.52 3.18 0 1.03 
305 0.56 40.57 1.67 57.51 4.29 1.92 7.10 1.12 
310 0.55 37.67 1.63 59.99 4.19 2.34 6.62 1.18 
315 0.49 39.75 1.59 57.34 3.94 2.91 4.45 1.16 
320 0.56 43.62 1.67 54.61 4.56 1.77 0.44 1.16 
325 0.58 42.19 1.69 56.23 5.01 1.58 5.68 1.10 
330 0.58 33.06 1.66 64.64 4.87 2.29 16.21 1.22 
335 0.63 44.26 1.74 54.38 5.64 1.36 6.77 1.25 
340 0.58 43.03 1.71 55.53 5.96 1.44 6.06 1.18 
17 
 
Table 4: Lifetime data extracted from 454 hours of ageing fibrillogenesis model including lifetime values (T1, T2, T3), 
pre-exponential values (A1, A2, A3), scatter component (Sc), χ
2
, and absorbance values for each corresponding 
wavelength.  
 
 
 
 
Table 5: Lifetime data extracted from 693 hours of ageing peptide model including lifetime values (T1, T2, T3), pre-
exponential values (A1, A2, A3), scatter component (Sc), χ2, and absorbance values for each corresponding 
wavelength. 
 
 
 
 
 
Wavelength 
/ nm 
T1 / ns A1 / % T2 / ns A2 / % T3 / ns A3 / % Sc / % χ2 
290 0.47 40.64 1.54 54.47 3.11 4.89 3.57 1.21 
295 0.56 43.15 1.66 54.87 3.95 1.99 2.97 1.12 
300 0.46 42.76 1.57 54.09 3.60 3.15 0.00 1.16 
305 0.53 39.45 1.63 58.25 4.17 2.29 4.88 1.09 
310 0.48 40.07 1.59 57.24 4.03 2.69 2.52 1.11 
315 0.52 41.06 1.63 56.72 4.30 2.22 2.51 1.13 
320 0.49 41.44 1.62 56.40 4.41 2.17 2.68 1.07 
325 0.54 44.31 1.68 53.94 4.80 1.75 2.52 1.13 
330 0.60 44.60 1.72 53.97 5.46 1.44 4.48 1.14 
335 0.58 46.76 1.72 51.81 5.65 1.42 2.50 1.10 
340 0.62 43.69 1.72 54.80 6.12 1.51 5.43 1.14 
Wavelength 
/ nm 
T1 / ns A1 / % T2 / ns A2 / % T3 / ns A3 / % Sc / % χ2 
290 1.46 82.83 2.77 32.08 3.08 -14.91 70.28 1.26 
295 1.57 93.63 3.97 107.85 4.01 -101.48 41.94 1.14 
300 1.55 94.35 3.54 5.66 350 -0.01 22.22 1.22 
305 1.55 94.35 3.65 5.66 350 -0.01 13.82 1.14 
310 0.67 14.41 1.64 81.21 3.73 4.37 9.13 1.04 
315 0.62 14.52 1.63 81.58 3.93 3.90 7.19 1.11 
320 1.12 42.67 1.90 55.75 4.99 1.59 6.27 1.16 
325 0.55 17.96 1.65 79.21 4.49 2.83 5.03 1.12 
330 0.55 21.27 1.69 76.58 5.07 2.15 4.74 1.12 
335 0.52 23.88 1.70 74.08 5.42 2.05 4.03 1.14 
340 0.75 28.20 1.77 69.98 6.23 1.82 5.44 1.15 
